Novavax (NVAX) has been struggling to convince the market that its COVID era gains can translate into a durable vaccine business, and the stock’s recent slide reflects those doubts. See our latest ...
Shares of two major Covid-19 vaccine makers declined Monday after a Food and Drug Administration official [claimed the shots]( ...
Novavax, Inc. reported 3Q25 EPS loss & declining revenue, but beat revenue expectations & reaffirmed its FY25 guidance. Read ...
4don MSN
FDA Vaccine Chief Claims COVID Shots Linked to 'At Least 10' Child Deaths but Offers No Data
US FDA's vaccine director Dr. Vinay Prasad wrote a memo to their staff that claimed multiple child deaths were related to ...
The FDA’s top vaccine regulator outlines proposed changes to the vaccine evaluation process in an internal memo.
Shares of vaccine makers slide as an internal FDA memo on vaccine safety and plans for stricter rules spark broad pressure across the overall industry.
FDA vaccines chief says internal review found 10 child deaths linked to Covid shots • Shift would remake flu immunization ...
Vinay Prasad, a top FDA official, blamed COVID shots for playing a role in the deaths of 10 children in a memo he sent to ...
Market Catalysts host Julie Hyman tracks several of the day's top trending stock tickers, including the stock hit vaccine ...
Get the latest on Novavax stock (NVAX) after breaking its losing streak. Discover updated profitability targets and analyst ratings.
A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback